Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories, Inc. Recalls

All product recalls associated with Dr. Reddy's Laboratories, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

99

Class I (Serious)

84

Most Recent

Dec 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1341–1360 of 2670 recalls

Zoledronic Acid Injection (Dr. Reddy's) – Impurity Specification Failure (2018)

Failed Impurities/Degradation Specifications: OOS for unknown impurities.

FDASep 12, 2018Nationwide• Dr. Reddy's Laboratories, Inc.

Zoledronic Acid Injection (Dr. Reddy's) – Impurity Specification Failure (2018)

Failed Impurities/Degradation Specifications: OOS for unknown impurities.

FDASep 12, 2018Nationwide• Dr. Reddy's Laboratories, Inc.

Lamotrigine Extended-Release Tablets (Torrent) – Dissolution Specification Failure (2018)

Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.

1...66 676869 70...134

Page 68 of 134Next

Class II

Moderate

FDASep 11, 2018Nationwide• Torrent Pharma Inc.

Tizanidine HCl Tablets (Dr. Reddy's) – foreign tablet mix (2018)

Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

Class IIModerate

FDASep 4, 2018Nationwide• Dr. Reddy's Laboratories, Inc.

NeoRelief Muscle Gel (BioLyte) – ingredient contamination (2018)

CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product.

Class IIModerate

FDAAug 31, 2018Nationwide• BioLyte Laboratories, LLC

2019 THOR MOTOR COACH OUTLAW Recall: ELECTRICAL SYSTEM

Thor Motor Coach (TMC) is recalling certain 2018-2019 Outlaw motorhomes, model 29J. The 12V wiring for the coach may have been improperly wired to the battery instead of wired through a circuit breaker.

NHTSAAug 29, 2018Nationwide• THOR MOTOR COACH

Amlodipine/Valsartan Tablets 10/320mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan Tablets 5/320mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Valsartan Tablets 160mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Valsartan Tablets 320mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan/HCTZ Tablets 5/160/12.5mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan/HCTZ Tablets 10/160/25mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan Tablets 5/160mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Valsartan Tablets 80mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan/HCTZ Tablets 10/320/25mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan Tablets 10/160mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan/HCTZ Tablets 5/160/25mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

Amlodipine/Valsartan/HCTZ Tablets 10/160/12.5mg (Torrent Pharma) – carcinogen impurity (2018)

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIModerate

FDAAug 17, 2018Nationwide• Torrent Pharma Inc.

CRF250R Motorcycle (Honda) – Crash and injury risk (2018)

This recall involves all 2018 Model Year CRF250R off-road motorcycles. The recalled motorcycles were sold in a red color. The names "HONDA" and "CRF250R" are printed on the sides of the motorcycle. The model name and model year are printed on a name plate label located at the front right top of the frame, near the steering head.

CPSCAug 16, 2018Nationwide• American Honda Motor Company Inc., of Torrance, Calif.

Diltiazem HCl Capsules (Mylan) – Impurity Specifications (2018)

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

FDAAug 14, 2018Nationwide• Mylan Institutional, Inc. (d.b.a. UDL Laboratories)